REFERENCES

1. Saad F, Caliber M, Doros G, Haider KS, Haider A. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality. Aging Male 2020;23:81-92.

2. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the international index of erectile function. Urology 1999;54:346-51.

3. Yafi FA, Jenkins L, Albersen M, et al. Erectile dysfunction. Nat Rev Dis Primers 2016;2:16003.

4. Traish AM, Haider A, Haider KS, Doros G, Saad F. Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Ther 2017;22:414-33.

5. Yeap BB, Dwivedi G. Androgens and cardiovascular disease in men. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279151/ [Last accessed on 18 Mar 2024].

6. Elagizi A, Köhler TS, Lavie CJ. Testosterone and cardiovascular health. Mayo Clin Proc 2018;93:83-100.

7. Mann A, Strange RC, König CS, et al. Testosterone replacement therapy: association with mortality in high-risk patient subgroups. Andrology 2023;Online ahead of print.

8. Mårin P, Holmäng S, Gustafsson C, et al. Androgen treatment of abdominally obese men. Obes Res 1993;1:245-51.

9. Jarvis TR, Chughtai B, Kaplan SA. Testosterone and benign prostatic hyperplasia. Asian J Androl 2015;17:212-6.

10. Thirumalai A, Anawalt BD. Epidemiology of male hypogonadism. Endocrinol Metab Clin North Am 2022;51:1-27.

11. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006;60:762-9.

12. Trussell JC, Delu A, Kiltz RJ, Kuznetsov VA. Defining hypogonadism in male partners of couples with unexplained infertility. Can J Urol 2020;27:10306-11.

13. Berg WT, Miner M. Hypogonadism and metabolic syndrome: review and update. Curr Opin Endocrinol Diabetes Obes 2020;27:404-10.

14. Lin L, Wang W, Xiao K, Guo X, Zhou L. Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia. J Endocrinol Invest 2023;46:2095-102.

15. Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J 1985;291:1693-7.

16. Snick HK, Snick TS, Evers JL, Collins JA. The spontaneous pregnancy prognosis in untreated subfertile couples: the Walcheren primary care study. Hum Reprod 1997;12:1582-8.

17. Morris G, Mavrelos D, Theodorou E, et al. Effect of paternal age on outcomes in assisted reproductive technology cycles: systematic review and meta-analysis. F&S Reviews 2020;1:16-34.

18. Buchanan JF, Davis LJ. Drug-induced infertility. Drug Intell Clin Pharm 1984;18:122-32.

19. Cocuzza M, Alvarenga C, Pagani R. The epidemiology and etiology of azoospermia. Clinics 2013;68 Suppl 1:15-26.

20. Bieth E, Hamdi SM, Mieusset R. Genetics of the congenital absence of the vas deferens. Hum Genet 2021;140:59-76.

21. Leaver RB. Male infertility: an overview of causes and treatment options. Br J Nurs 2016;25:S35-40.

22. Dhindsa S, Ghanim H, Jenkins T, et al. High prevalence of subnormal testosterone in obese adolescent males: reversal with bariatric surgery. Eur J Endocrinol 2022;186:319-27.

23. Minhas S, Bettocchi C, Boeri L, et al. EAU Working Group on Male Sexual and Reproductive Health. European association of urology guidelines on male sexual and reproductive health: 2021 update on male infertility. Eur Urol 2021;80:603-20.

24. Esteves SC, Miyaoka R, Roque M, Agarwal A. Outcome of varicocele repair in men with nonobstructive azoospermia: systematic review and meta-analysis. Asian J Androl 2016;18:246-53.

25. Kirby EW, Wiener LE, Rajanahally S, Crowell K, Coward RM. Undergoing varicocele repair before assisted reproduction improves pregnancy rate and live birth rate in azoospermic and oligospermic men with a varicocele: a systematic review and meta-analysis. Fertil Steril 2016;106:1338-43.

26. Morris GC, Lloyd-Evans E, Cahill DJ. Induction of spermatogenesis in men with hypogonadotropic hypogonadism. J Assist Reprod Genet 2021;38:803-7.

27. Morris G, Cahill DJ. Fertility treatments for men with hypogonadotropic hypogonadism. J Cancer Biol 2021;2:44-50.

28. Sohan K, Cahill D, Stegmann M. Local reaction to S.C. injections of a recombinant gonadotrophin preparation possibly related to the osmolality of the reconstituted solution. Hum Reprod 1999;14:1921.

29. Holt-Kentwell A, Cahill D. Induction of spermatogenesis in men with hypogonadotrophic hypogonadism - is treatment available in UK fertility clinics? BJOG An International Journal of Obstetrics and Gynaecology 2019;126:209.

30. Wittert GA, Robledo KP, Grossmann M, et al. 274-OR: effect of testosterone treatment on type 2 diabetes incidence in high-risk men enrolled in a lifestyle program: a two-year randomized placebo-controlled trial. Diabetes 2020;69:274-OR.